Patents by Inventor Emmanuel Guerin

Emmanuel Guerin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210169266
    Abstract: An automatic brewing system includes a brewer, a brewing-substance delivery system coupled to the brewer, and a water-delivery system coupled to the brewer. The brewer, brewing-substance delivery system and water-delivery system are stored in a housing. The brewing-substance delivery system delivers brewing substance into the brewer for combination with water supplied by the water-delivery system to form a brewed beverage.
    Type: Application
    Filed: April 30, 2019
    Publication date: June 10, 2021
    Inventors: Emmanuel GUERIN, Nicolas TROCHERIS, Thierry GROULT
  • Patent number: 9616071
    Abstract: An oral sustained release pharmaceutical composition comprising a plurality of granules having diameters of not more than 1000 ?m, wherein each of the granules comprise a nucleus granule comprised of beraprost sodium and a coating agent coating the nucleus granule, and wherein the coating agent is comprised of a first skin layer containing one or more relatively water-insoluble macromolecular substances, and a second skin layer containing one or more hot-melt low-melting substances.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: April 11, 2017
    Assignees: ETHYPHARM, TORAY INDUSTRIES, INC.
    Inventors: Sandrine Salle, Emmanuel Guerin
  • Publication number: 20110293715
    Abstract: The present invention relates to a multiparticulate tablet with improved gastro-protection comprising at least a pharmaceutically active substance in the form of enteric coated particles, and a mixture of tableting excipients, wherein the said mixture of excipients comprising xylitol and/or maltitol, each in a directly compressible form, a disintegrating agent, a lubricant and at least one other diluent and the ratio of a) the xylitol and/or the maltitol to b) the other diluent(s) is less than 5/95 (weight/weight) and the result of the “test of integrity of the film” is greater than 95%, preferably greater than 97% and more preferably still greater than 99% and the result of the “release test” is greater than 90%, preferably greater than 95%. According to one embodiment of the invention, the active substance is omeprazole or esomeprazole. According to another embodiment the tablet is a disintegratable tablet, which disintegrate in the mouth with or without chewing.
    Type: Application
    Filed: November 30, 2010
    Publication date: December 1, 2011
    Inventors: Danielle Combessis, David Corvaisier, Alexandre Gil, Emmanuel Guerin
  • Publication number: 20070269506
    Abstract: An oral sustained release pharmaceutical composition comprising a plurality of granules having diameters of not more than 1000 ?m, wherein each of the granules comprise a nucleus granule comprised of beraprost sodium and a coating agent coating the nucleus granule, and wherein the coating agent is comprised of a first skin layer containing one or more relatively water-insoluble macromolecular substances, and a second skin layer containing one or more hot-melt low-melting substances.
    Type: Application
    Filed: May 19, 2004
    Publication date: November 22, 2007
    Applicant: Toray Industries , Inc.
    Inventors: Sandrine Salle, Emmanuel Guerin
  • Publication number: 20060018964
    Abstract: The present invention relates to a multiparticulate tablet with improved gastro-protection comprising at least a pharmaceutically active substance in the form of enteric coated particles, and a mixture of tableting excipients, wherein the said mixture of excipients comprising xylitol and/or maltitol, each in a directly compressible form, a disintegrating agent, a lubricant and at least one other diluent and the ratio of a) the xylitol and/or the maltitol to b) the other diluent(s) is less than 5/95 (weight/weight) and the result of the “test of integrity of the film” is greater than 95%, preferably greater than 97% and more preferably still greater than 99% and the result of the “release test” is greater than 90%, preferably greater than 95%. According to one embodiment of the invention, the active substance is omeprazole or esomeprazole. According to another embodiment the tablet is a disintegratable tablet, which disintegrate in the mouth with or without chewing.
    Type: Application
    Filed: July 13, 2005
    Publication date: January 26, 2006
    Inventors: Danielle Combessis, David Corvaisier, Alexandre Gil, Emmanuel Guerin
  • Patent number: 6794411
    Abstract: The invention relates to a drinkable ibuprofen solution wherein the soluble fraction of the active ingredient contained therein is less than 10% by weight in relation to the weight of the suspension.
    Type: Grant
    Filed: November 6, 2001
    Date of Patent: September 21, 2004
    Assignee: Laboratoire des Produits Ethiques Ethypharm
    Inventors: Christophe Lebon, Emmanuel Guerin, Pascal Suplie
  • Patent number: 6110307
    Abstract: The present invention relates to a compacting process suitable particularly for the compacting of materials with a pyrophoric tendency and especially for the compacting of scrap metal generated in the nuclear industry: and compacting means (4), and a compacting device including said means (4), appropriate for the implementation of said process. In said process the blanketed materials are compacted with optimized complementary external blanketing. The inert gas used for said external blanketing is characteristically conveyed via the compacting means (4) and blown in through their lower end (15).
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: August 29, 2000
    Assignee: Compagnie Generale des Matieres Nucleaires
    Inventors: Jean-Claude Guerin, deceased, by Robert Rene Armand Guerin, heir, by Christiane Guerin, heir, by Jean-Baptiste Guerin, heir, by Agnes Fernande Cano, heir, by Pierre Emmanuel Guerin, heir, Philippe Kerrien, Gerard Limeuil